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Abstract
Background: To study the biological function of miRNAs, and to achieve sustained or conditional gene silencing
with siRNAs, systems that allow controlled expression of these small RNAs are desirable. Methods for cell delivery
of siRNAs include transient transfection of synthetic siRNAs and expression of siRNAs in the form of short hairpins
using constitutive RNA polymerase III promoters. Systems employing constitutive RNA polymerase II promoters
have been used to express miRNAs. However, for many experimental systems these methods do not offer
sufficient control over expression.
Results: We present an inducible mammalian expression system that allows for the conditional expression of short
hairpin RNAs that are processed in vivo to generate miRNAs or siRNAs. Using modified nuclear receptors in a two
hybrid format and a synthetic ligand, the Rheoswitch system allows rapid and reversible induction of mRNA
expression. We evaluated the system’s properties using miR-122 as a model miRNA. A short hairpin encoding miR-
122 cloned into the expression vector was correctly processed to yield mature miRNA upon induction with ligand
and the amount of miRNA produced was commensurate with the concentration of ligand. miR-122 produced in
this way was capable of silencing both endogenous target genes and appropriately designed reporter genes.
Stable cell lines were obtained, resulting in heritable, consistent and reversible expression of miR-122, a significant
advantage over transient transfection. Based on these results, obtained with a microRNA we adapted the method
to produce a desired siRNA by designing short hairpins that can be accurately and efficiently processed.
Conclusion: We established an Inducible expression system with a miR-122 backbone that can be used for
functional studies of miRNAs and their targets, in heterologous cells that do not normally express the miRNA.
Additionally we demonstrate the feasibility of using the miR-122 backbone to express shRNA with a desired siRNA
guide strand for inducible RNAi silencing.
Background
There is a growing awareness of the significance of
small RNAs in biology, which has led to increased use
of small RNAs as tools in biological research. For exam-
ple, microRNAs (miRNAs) are small non-coding RNAs
that regulate gene expression by reducing the stability
or the translation of partially complementary mRNA
[1,2] and up to 30% of human genes may be regulated
by miRNAs [3,4]. RNAi, mediated by short double-
stranded RNAs (siRNAs), has become a powerful tool
for analyzing gene function through targeted gene
knock down [5]. Improved methods for controlled
expression of small RNAs in the cell will advance the
study of their roles in biological processes.
miRNA genes are transcribed by RNA polymerase II
(pol II) and the primary transcript is processed in vivo
to yield first a short hairpin, and finally a 21-23 nt
miRNA [6]. Synthetic siRNA can be synthesized in vitro
and delivered to cells by transfection. Alternatively,
short RNA hairpins that mimic a miRNA precursor can
be expressed in the cell using either plasmid or viral
vectors. The resulting transcript is processed in vivo to
yield a small RNA that can function as an siRNA, or a
miRNA, inducing specific degradation of targets, similar
to transfected siRNA [7,8]. For certain RNAi applica-
tions, expression of short hairpins offers advantages over
transient transfection of siRNA. Expression vectors can
be transiently transfected or integrated into the cellular
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provides consistent, long-term expression of the short
hairpin as compared with transient transfection of
siRNA. Early expression vectors used the U6 and H1
RNA polymerase III (pol III) promoters which use dis-
crete initiation and termination marks [9,10]. Constitu-
tive pol II promoters, such as CMV [6,7] or UbC [8],
have also been used (reviewed in [9]). But in many
cases, such as analysis of essential genes, a conditional
expression system that can produce siRNA or miRNA
on demand or for a limited time is required. While pol
III promoters allow a high level of expression they are
naturally constitutive. Efforts to engineer pol III systems
under drug-mediated control (e.g. Tet-based systems)
have compromised either the tight repression of expres-
sion in the OFF state [11] or the high level of expression
in the ON state [12]. The advantage of the Tet system is
that expression is reversible upon drug withdrawal.
Pol II based expression systems offer better control
through the use of tissue specific or conditional promo-
ters. A variety of regulated systems have been developed
for inducible gene expression (see [13] for review) but
perhaps the most widely used are the doxycycline and
ecdysone controlled systems [14]. An improved version
of the ecdysone-inducible approach is a two-hybrid ver-
sion, also known as the Rheoswitch system, which uses
an artificial heterodimeric nuclear receptor for ligand-
induced transcription of a gene cloned into an expres-
sion plasmid [15]. Two modified nuclear receptors,
“RheoReceptor-1” and “RheoActivator”,d r i v e nb yc o n -
s t i t u t i v ep r o m o t e r sa r ec a r r i e do no n ep l a s m i d .T h e
“RheoReceptor-1” is a fusion of the GAL4 DNA binding
domain with a modified ecdysone receptor (EcR) ligand
binding domain. The “RheoActivator” is a fusion of the
viral transcription activation domain VP16 with a chi-
meric mammalian/insect RXR ligand binding domain.
The transcription unit of interest is cloned downstream
of five GAL4 response elements (UAS) in a separate
expression plasmid [15] (Figure 1a). Instead of ecdysone,
a non-steroidal diphenylhydrazine compound, RSL1,
acts as a specific ligand that stabilizes the nuclear recep-
tor heterodimer and activates transcription of the cloned
gene of interest. This combination of chimeric receptors
with a non-steroidal synthetic ligand was designed to
ensure that the expression system will not interfere with
endogenous cellular pathways [16]. RSL1 (as opposed to
ecdysteroids) has shown minimal effects on endogenous
gene expression and cell proliferation in prostate cells
[17] and in HEK293 cells [18]. In addition to these sys-
tems, Rheoswitch has been used to induce expression of
proteins in mice, MBT-2 and Panc02 carcinoma cells
[19] and NIH3T3 cells [15]. However, no gene silencing
studies using this system have yet been published. In
this study, we used Rheoswitch to produce RNAs that
are processed in vivo in mammalian cultured cells to
generate miRNAs that are functional in target gene
knockdown.
Results and Discussion
Inducible expression of miR-122
We chose miR-122, an abundantly expressed miRNA, as
a model for inducible shRNA expression. miR-122 is
expressed exclusively in the liver [20] and plays a key
role in the regulation of cholesterol and fatty acid meta-
bolism in the adult liver [21]. In hepatocarcinoma of
humans and rodents, miR-122 has been reported to be
specifically down-regulated to a significant degree [22].
Hepatoma cell lines expressing miR-122, such as Huh-7,
are required for the propagation and study of hepatitis
C virus (HCV). HepG2, which does not express detect-
able miR-122 is resistant to HCV infection [23].
Recently, the first miRNA-based drug has been shown
to be protective against HCV infection in primates [24].
These properties of miR-122 have made it a highly stu-
died miRNA and a prime target for therapeutics
development.
To determine whether the Rheoswitch expression sys-
tem could be used to induce expression of short hairpin
RNAs, a 385 bp human genomic DNA fragment con-
taining miR-122 and its flanking DNA sequence was
cloned downstream of the GAL4 binding sites in the
Rheoswitch expression vector pNEBR-X1. Transient
transfection of this plasmid into human embryonic kid-
ney cells stably expressing RheoReceptor and RheoActi-
vator (HEK293-A7) demonstrated production of mature
miR-122 upon induction with RSL1 (Figure 1b). Based
on these results and additional transient transfection
experiments (data not shown), we constructed a cell line
that carried integrated miR-122 expression vector
(NIH3T3-47/miR-122) in mouse embryo fibroblasts,
which also stably express the Rheoswitch proteins. We
used this cell line to investigate the properties of
induced miR-122 expression.
First, we confirmed that RSL1 treatment could induce
the cells to produce mature miR-122 miRNA. Northern
blot analysis demonstrated that RSL1-treated cells pro-
duced the 23 nt guide strand, whereas the passenger
strand was undetectable, indicating that the miR-122
primary transcript is induced and correctly processed
(Figure 1c, top panel). In the absence of RSL1, cells did
not produce any detectable passenger or guide strand.
Induction of the cells for 24 hours using different con-
centrations of RSL1 showed that the amount of accumu-
lating mature miR-122 could be modulated by the
concentration of the inducer (Figure 1c, bottom panel).
One advantage of small molecule ligands such as RSL1
is the ability to diffuse into cells to rapidly induce, or
turn off expression, in a dose-dependent manner [19].
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Page 2 of 13Figure 1 Characteristics of inducible miR-122 expression with Rheoswitch. a. RSL1 structure and schematic representation of the
Rheoswitch system. b-f: Northern blot analyses of total RNA from non-induced (DMSO) and induced (RSL1) cells treated as indicated for each
panel. b. HEK293-A7 cells transiently transfected with pNEBRX-1 containing a genomic miR-122 fragment. c. Top panel: Production of miR-122
guide vs. passenger strand: stably transformed NIH3T3-47-miR122 cells were treated as indicated. Bottom panel: RSL1 concentration-dependent
expression of miR-122. Cells were treated with DMSO (lane 1) or increasing concentrations of RSL1 (50 nM, 500 nM or 5 μM, lanes 2-4)Probe:
miR-122 guide strand. d. Time course of induction: RNA was prepared from cells at times indicated, beginning 2 hours after addition of DMSO
(left) or RSL1 (right). Note that although the 24 h non-induced cell RNA sample is overloaded no miR-122 guide strand is detected. e. miR-122
expression in human hepatocarcinoma derived HepG2 and Huh7 cell lines. f. Switch on/off properties. Top: schematic representation of
treatment regimen and sampling times. Each row (I to IV) of the scheme corresponds to a row on the northern blot below. Time is indicated as
days elapsed, + RSL1 (shaded) and - RSL1 (clear). Bottom: Northern blot of total RNA hybridized with miR-122 guide strand probe (left) or U6
control (right). See Methods for probe sequences.
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nation of the induction time course and ON-OFF switch-
ing was performed. miR-122 guide strand was detectable
2 hours after induction, its level peaked at about 8 hours
post-induction and remained at that level after 24 hours,
indicating rapid induction and steady levels of miRNA
production (Figure 1d). These results demonstrate that,
in principle, the NIH3T3-47/miR-122 cell line can
become miR-122 positive or negative, depending on the
presence or absence of RSL1 in the culture medium,
mimicking Huh-7 or HepG2 hepatic cells respectively in
terms of miR-122 expression status (Figure 1e).
We studied long-term expression and switching prop-
erties by maintaining the cells under non-induced or
continuous induction conditions for several days. Non-
induced cells showed no detectable miR-122 accumula-
tion after 7 days in culture, while induced cells
expressed miR-122 for at least 7 days, demonstrating
tight control of the OFF state (Figure 1f, rows I and II).
Next, we tested the reversibility of the switch. Cells
were treated with RSL1 for 24 hours, RSL1 was then
withdrawn. miR-122 expression was reduced over the
course of the next days, reaching non-induced levels by
day 7 (Figure 1f, row III). A second induction at day 4
can restore expression to the fully induced levels (Figure
1f, row IV). These results demonstrate that induced
expression of miRNA using this system is sustainable
and reversible, allowing control of expression of the
cloned miRNA.
Inducible and regulated silencing
Since this system proved suitable for controlled expres-
sion of miR-122, we tested whether the induced miRNA
expression can be used in turn for controlled target
gene silencing. First, we designed a reporter-based assay
using the secreted Gaussia luciferase (GLuc). We had
previously used a GLuc-based reporter for assessing
siRNA potency [25]. Two tandem copies of a sequence
complementary to the miR-122 guide strand were
inserted into the 3’ UTR of a GLuc reporter (pTK-
GLuc-miR122) (Figure 2a). The miR-122 guide strand
should work, in this instance, like an siRNA because it
perfectly matches its target in the 3’ UTR of the GLuc
mRNA. We transfected pTK-GLuc-miR122 or control
pTK-GLuc reporter into the NIH3T3-47/miR-122 cells
and measured the secreted luciferase activity after differ-
ent treatments. GLuc expression was unaffected in non-
induced cells, but was substantially reduced following
induction of miR-122 expression (Figure 2b, left panel).
Consistent with the reversible miR-122 expression
( s h o w na b o v ei nF i g u r e1 f ) ,G L u ce x p r e s s i o nw a s
restored following withdrawal of RSL1 (Figure 2b, left
panel), demonstrating reversible knock down of the tar-
get. Knockdown of GLuc expression was target-specific
since the control reporter lacking the miR-122 target
sites was unaffected by any treatment (Figure 2b, left
panel). Since the secreted luciferase assay is non-
destructive, we used the same cells to correlate the
expression status of the miR-122 guide strand detected
by Northern hybridization. Consistent with the lucifer-
ase expression level, miR-122 was detected only under
inducing conditions (RSL1 treatment). Following RSL1
withdrawal, miR-122 declined over the next 24 hours
(Figure 2b, right panel).
Since this system showed regulation of miRNA output
by varying the concentration of the inducer (see Figure
1c), we tested whether the downstream effects of miR-
122 expression were also RSL1 concentration-depen-
dent. When expression of the pTK-GLuc-miR122
reporter was assayed after treatment with increasing
concentrations of RSL1, a corresponding decrease in
Gaussia luciferase activity was observed, whereas the
activity from cells transfected with the control vector
produced normal amounts of luciferase (Figure 2c).
Western blot analysis confirmed that the loss of mea-
sured luciferase activity reflects the decreased GLuc pro-
tein levels as a result of miRNA targeting (Figure 2c).
These results demonstrate that miR-122 short hairpin-
mediated target silencing can be controlled in an RSL1
dose-dependent manner.
Induced silencing of miR-122 target genes
We demonstrated that induced expression of the guide
strand of miR-122, acting as an siRNA, can silence an
artificial reporter gene with a perfectly matched target
sequence present in its 3’ UTR (Figure 2b). To test
whether the system could be used for “natural” miRNA
target validation we attempted to recapitulate the silen-
cing activity of miR-122 through its interaction with the
3’-UTR of previously identified target genes such as gly-
cogen synthase (GYS) [21]. The 3’ UTR of GYS was
cloned downstream of GLuc in the pTK-GLuc reporter
vector and the resulting construct (pTK-GLuc-GYS) was
transfected into the miR-122 expressing stable cell line
NIH3T3-47/miR-122. Upon RSL1 induction, Gaussia
luciferase activity from cells transfected with the GYS
reporter was reduced to 76% of control expression (Fig-
ure 3a). This knockdown is target sequence-specific
since luciferase activity from cells transfected with pTK-
GLuc control plasmid with an unrelated UTR was unaf-
fected by miR-122 induction (Figure 3a). A similar
reduction was observed using GLuc reporter assays for
another miR-122 target, CAT1 [26] (data not shown).
In order to further test this miRNA target validation
methodology with an endogenous (not transfected) gene
target, we tested the effect of induced miR-122 expres-
sion on aldolase A, a validated miR-122 target in mouse
liver, [21]. We confirmed by Western blot analysis that
aldolase A is expressed in uninduced NIH3T3-47/miR-
122 cells (Figure 3b, DMSO lane). We monitored
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Page 4 of 13Figure 2 GLuc-miR-122 reporter knockdown by inducible short hairpin expression is reversible and RSL1 concentration-dependent.a .
Gaussia luciferase (GLuc) reporters used in transfections: pTKGLuc: Gaussia luciferase under control of the constitutive HSV-TK promoter;
pTKGLuc-miR122 carries two tandem miR-122 targets (arrows) inserted in the 3’ untranslated region of GLuc. b. Left panel: NIH3T3-47/X1-miR122
cells were transfected with pTKGLuc-miR122 or pTKGLuc and treated with DMSO (white bars) or 0.5 μM RSL1 (gray bars) for 48 h, or 0.5 μM RSL1
for 24 h followed by DMSO (RSL1/DMSO, black bars) for 24 h. GLuc reporter activity was assayed from transfected cell culture supernatants and
RNA was prepared from the same cells. Values are expressed as a percent of the mean GLuc activity of non-induced cells (+/- 1SD). Right panel:
Northern blot analysis of RNA prepared from the cells transfected and treated as shown in Left panel. Probes: miR-122 guide strand (top), U6
loading control (bottom). c. NIH3T3-47/X1-miR122 cells were transfected with pTKGLuc-miR122 or control pTKGLuc plasmid, and treated with
DMSO or increasing concentrations of RSL1. Mean GLuc activity of induced cells is expressed relative to mean GLuc activity of non-induced
(DMSO-treated) cells (+/- 1SD). Western blot: cell culture supernatants from c, detected with anti-GLuc antibody. Lane 1: DMSO; lanes 2-4: 0.05
μM, 0.5 μM and 5.0 μM RSL1 respectively.
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Page 5 of 13aldolase-A protein levels by immunoblot over the course
of miR-122 induction. In the presence of RSL1 NIH3T3-
47/miR-122 cells show a gradual reduction of aldolase A
protein to 75% of control in 3 days and 31% of control
levels after 9 days compared to time-matched non-
induced NIH3T3-47/miR-122 control cells (Figure 3b,
RSL1 lanes, and data not shown). Thus we achieved
modulation of aldolase-A protein expression with small
molecule induction of ectopic miR-122 expression.
These results suggest that miRNA target gene validation
and phenotypic analysis can be easily obtained using
this inducible miRNA system.
Expression of inducible shRNA
To test whether artificial short hairpins could be
expressed and properly processed to produce a designed
guide strand, different short hairpin configurations car-
rying the same inserted guide strand sequence were
cloned in the Rheoswitch expression vector pNEBRX1
(Figure 4a). The sequence and structure of the short
hairpins in pNEBRX-Sh-1 and pNEBRX-Sh-2 were mod-
eled on miR-30 as previously described [8]. In pNEBRX-
Sh-1, the short hairpin sequence is cloned directly into
the MCS of the vector. The hairpin sequence in
pNEBRX-Sh-2 is the same as pNEBRX-Sh-1, but it is
inserted in the place of miR-122 in the 385 bp genomic
DNA fragment used above for miR122 expression.
pNEBRX-Sh-3 uses the structure of the miR-122 short
hairpin but it contains the same guide strand as Sh-1
and Sh-2. Compensatory changes were made in the
stem sequence in order to maintain a miR-122-like
(bulged) structure. Plasmids encoding these short hair-
pins were transfected into NIH3T3-47 cells, expression
was induced by RSL1 and Northern blot analysis using
guide strand-specific probes was used to evaluate hair-
pin processing. Sh-1 produced little RNA of the
expected size(21-23 nt), perhaps because the stem-loop
structure was not conducive to optimal processing (Fig-
ure 4b). Sh-2 produced more, suggesting that processing
is more efficient if the short hairpin is surrounded by
miR-122 genomic sequences. Sh-3, which most closely
mimics miR-122 produced the most mature guide
strand (Figure 4b). These results suggest that the miR-
Figure 3 Knock down of target genes by induced expression of miR-122. a. Glycogen synthase-3’ UTR targeted by miR-122. NIH3T3-47/X1-
miR122 cells were transfected with reporter plasmids pTKGLuc (control), or pTKGLuc-GYS with the (glycogen synthase 3’ untranslated region
(UTR) and mIR-122 target sites schematic, top panel). The luciferase activity remaining 48 h after induction is plotted as a percent of activity from
control cells. (*p = 0.0255; Error bar = -/+1SD) (See Methods for 3’ UTR sequence coordinates.) b. Western blot analysis of aldolase A, an
endogenous target of miR-122,. NIH3T3-47/X1-miR122 cells were treated with DMSO or 0.5 μM RSL1, then cell lysates were used for western blot
analysis. The sample of 9 days post treatment is shown. Aldolase A protein quantification was calculated after LiCor scanning of Western blot
normalized for loading with alpha-beta tubulin. A single miR-122 target site in aldo A is located at position 27-34 in the aldoA 3’ UTR (top
panel).
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Page 6 of 13122 stem loop structure more readily accommodates
guide strand sequence variants than the miR-30 stem
loop structure.
Inducible siRNA production for controlled target knock
down
One hurdle in using an inducible shRNA expression sys-
tems is to reliably convert a desired siRNA into an
inducible hairpin that can silence target genes. This pro-
cess is not always straightforward. We tested whether
the miR-122 backbone in the Rheoswitch expression
vector could be used as a platform for inducible expres-
sion of a shRNA with a desired sequence for RNAi
silencing. To test the system, we chose a previously
described siRNA directed against a 19 nt sequence of
Figure 4 Test of different hairpin designs reveals most efficient processing of small RNA from short hairpins based on the miR-122
structure. a. Sequence of different short hairpin RNAs expressed from the inducible pNEBR-X1 vector. miR122 stem-loop (blue); surrounding
genomic DNA sequence (black); MCS of the vector (gray lines); a short hairpin based on miR-30 (green), carrying a new guide strand sequence
(red). b. Northern blots of resulting short RNAs from the short hairpin plasmids described in (a) or empty vector. The plasmids were transfected
into NIH3T3-47 cells, which were treated with 0.5 μM RSL1 or DMSO for 48 h. Short hairpins were detected with probes complementary to the
guide strand for Sh-1, -2, -3 or miR-122, respectively; U6 hybridization was used as loading control. (See Methods for probe sequences.)
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Page 7 of 13firefly luciferase (pGL3-FLuc) [27]. Based on our pre-
vious results (Figure 4), we replaced the 23 nt guide
strand of miR-122 in pNEBRX-miR-122 with the FLuc
siRNA guide strand in a structure similar to Sh-3 (Fig-
ure 4a). Because the published (matching) guide strand
sequence was 19 nt long, four nucleotides shorter than
the miR-122 guide strand, we added four nucleotides
(derived from the sequence of firefly luciferase) to the 3’
end of the FLuc guide strand in order to maintain the
structure of the miR-122 short hairpin (Figure 5a). The
miR-122 stem contains a bulge, so we designed one
short hairpin, FLuc-ShM, with an internal mismatch in
order to mimic the miR-122 structure. A second FLuc
short hairpin, FLuc-Sh was designed with a perfectly
complementary stem structure (Figure 5a). Additionally,
based on our Northern blot results with Sh-2 (Figure 4a,
b), we tested whether surrounding the FLuc short hair-
pin with miR-122 genomic flanking sequence has an
effect on its silencing properties. Therefore, we inserted
both the mismatched and perfectly complementary FLuc
short hairpins into the Rheoswitch expression vector
either surrounded by genomic sequences (FLuc-ShMG
and FLuc-ShG) or directly cloned into the MCS of the
vector (FLuc-ShM, FLuc-Sh).
The FLuc short hairpin plasmids or an equivalent
miR-122 short hairpin plasmid (miR122Sh or miR122G)
were co-transfected with an FLuc reporter plasmid into
Rheoswitch cells and compared for induced knockdown
of firefly luciferase. All of the FLuc short hairpin designs
were effective in reducing luciferase activity upon RSL1
induction (Figure 5b) while the control miR-122 had no
effect on the luciferase reporter activity. The stem-mis-
matched short hairpins (FLuc-ShM, FLuc-ShMG), which
more closely mimic the miR-122 structure, were slightly
more effective in knocking down the FLuc reporter than
the perfectly matched hairpin designs (FLuc-Sh, FLuc-
ShG). The surrounding DNA context had no significant
effect on the knockdown obtained by either FLuc short
hairpin, i.e., short hairpins flanked by genomic
sequences were neither more nor less effective than
those flanked by the MCS of the vector (Figure 5b).
Taken together these results provide guidance in
designing shRNA expression constructs. Short hairpins
b a s e do nt h em i R - 1 2 2s t e ml o o ps t r u c t u r ec a np r o d u c e
more miRNA guide strand than short hairpins based on
the miR-30 structure (Figure 4b, compare miR-122 and
Sh-3 to Sh-1 and Sh-2). If the short hairpin was not
readily processed, as was the case with the mir-30-like
Sh-1, addition of flanking sequence increased the pro-
cessing efficiency (compare Sh-2 to Sh-1). Neither Sh-1
nor Sh-2 produced as much miRNA as the miR-122
short hairpin or the miR-122-like Sh-3. It seems prob-
able that Sh-3 produced more mature miRNA than Sh-1
and Sh-2 because it is a variant of the miR-122 short
hairpin, rather than because of the genomic DNA that
flanks it (Figure 4a).
The designs with the bulge in the stem (FLuc-ShM
and FLuc-ShMG), mimicking the structure of miR-122,
were slightly more effective in target knockdown than
those perfectly complementary (FLuc-Sh and FLuc-
ShG). The target knockdown results support the conclu-
sion that in determining the processing efficiency and
silencing effectiveness in the structure of the short hair-
pin is more important than the sequence context in
which it is transcribed, and the miR-122 stem-loop
s t r u c t u r ei saf a v o r a b l ev e h i c l ef o rs h o r th a i r p i n
expression.
Conclusions
We have shown that in addition to controlled protein
expression, the Rheoswitch ligand-inducible system
allows regulated expression of short hairpin RNA. By
varying the dose of RSL1, the RNA expression level can
be modulated, and upon RSL1 withdrawal, expression is
turned off. This feature is important when studying bio-
logical phenomena resulting from down-regulation, but
not elimination, of gene function. Expression can be
turned on and off repeatedly, allowing additional control
for studying a range of experimental states, an advantage
when studying essential genes. Short hairpins can be
expressed and the RNA processed to yield miRNA
(miR-122) or siRNA (FLuc). The expressed miRNAs
function as expected in target knockdown using endo-
genous targets, such as aldolase-A, or reporter-3’ UTR
targets (e.g., GYS), facilitating miRNA target validation
assays. We explored whether novel guide strand
sequences, such as those based on an siRNA, can be
incorporated into the miR-122 short hairpin, expressed
and processed to yield functional small RNAs. Our
experiments suggest that the miR-122 backbone can be
adapted for inducible siRNA expression. It has been
shown that multiple shRNAs, directed at multiple tar-
gets, can be expressed from a single transcription unit
[28]. The Rheoswitch system accommodates long tran-
scription units, unlike pol III systems that require short
transcripts. This suggests that it may be possible to
build a Rheoswitch expression vector with two or more
shRNAs in tandem.
Methods
Construction of short hairpins in Rheoswitch expression
vector pNEBRX1
pNEBRX1-miR-122: A 385 bp miR-122 genomic frag-
ment was generated by PCR using 2× Taq mix (NEB)
and human genomic DNA (Novagen) using the follow-
ing primers:
5’ GTCACTAAGCTTCAGCTCTTCCCATTGCTCAAGATGC
3’ and
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Page 8 of 13Figure 5 Short hairpins based on miR-122 designed to express a particular siRNA guide strand. An siRNA sequence used previously to
silence firefly luciferase (FLuc) was placed in the miR-122 stem-loop structure as shown schematically. a. Top: The sequence of the FLuc target
mRNA (shown 3’ to 5’) was used to extend the complementary siRNA guide strand (middle underlined). Bottom: Schematic representation of the
two short hairpins designed to express firefly luciferase siRNA. The 19 nt sequence of the FLuc siRNA guide strand is underlined. The sequence
of the miRNA expected from these short hairpins is 23 nt in length (black). FLuc-ShM contains a mismatch (magenta). Sequence residues
originating from the miR-122 pre-miRNA are blue. All hairpin forms are designed to produce identical guide strand sequences. b. Inducible
silencing of firefly luciferase. FLuc short hairpin constructs were transiently transfected into NIH3T3-47 cells along with the Fluc reporter plasmid
pGL3Luc and pCMV-lacZ as a transfection control. Cells were treated with 0.5 μM RSL1 or DMSO for 48 h, and cell lysates were subsequently
assayed for firefly luciferase and b-galactosidase for normalization. The luciferase activity remaining 48 h after induction is shown as a percent of
activity from matched transfected non-induced cells. Results represent the mean (+/- SD) of 3 experiments. p-values represent comparison of
percent remaining activity for FLuc short hairpins vs. non-targeting control miR-122 short hairpins. * p < 0.01, ** p < 0.001.
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Page 9 of 135’ GTCACTGGATCCGTGAGAGGCAGGGTTCAGCTAACCA
3’.
Vector pNEBR-X1(puro) was obtained by cloning a
puromycin resistance cassette (PvuII-BamHI fragment)
from pPur (BD Biosciences) into pNEBR-X1 (NEB). The
miR-122 genomic PCR product and vector pNEBR-X1
(puro) were digested with HindIII and BamHI and
ligated together.
pNEBRX1-FLuc-Sh, pNEBRX1-ShM, pNEBRX1-miR-
122sh and pNEBRX-Sh-1 were constructed by first
annealing complementary oligonucleotides. Top and
bottom oligonucleotides (50 pmoles each) were annealed
by heating to 95°C and cooling slowly to 25°C in 10 mM
TRIS pH 8.0. The resulting double-stranded DNA frag-
ments with cohesive ends were ligated to appropriately
digested pNEBR-X1, and transformed into competent E.
coli strain NEB10beta (NEB). The following oligonucleo-
tides were used:
FLuc-Sh BamHI top:
GATCCCCTTAGCAGAGCTGTCGAAGTACTCAGCGTAA
GTGATGTCTAAACTATT
CACTTACGCTGAGTACTTAAATAGCTACTGCTAGGCC
FLuc-Sh XhoI bottom: TCGAGGCCTAGCAGTAGC
TATTTAAGTACTCAGCGTAAGTGAATAGTTTAGA
CATCACTTACGCTGAGTACTTCGACAGCTCTGC
TAAGGG
FLuc-ShM BamHI top: GATCCCCTTAGCA-
GAGCTGTCGA AGTACTCAGCGTAAGTGATGTCTAAACTA
TTCACTTACGCTAAGTACTTAAATAGCTACTGCTAGGCC
FLuc-ShM XhoI bottom:
TCGAGGCCTAGCAGTAGCTATTTAAGTACTTAGCGTAA
GTGAATAGTTTAGACATCACTTACGCTGAGTACTTCGA
CAGCTCTGCTAAGGG
miR-122Sh BamHI top: GATCCCCTTAGCA-
GAGCTGTGGAGTGTGACAATGGTGTTTGTGTCTAAAC-
TATCAAACGCCATTATCACACT AAATAGCTACTGCTA
GGCC
miR-122Sh XhoI bottom:
TCGAGGCCTAGCAGTAGCTATTTAGTGTGATAATGGC
GTTTGATAGTTTAGACACAAACACCATTGTCACACTC
CACAGCTCTGCTAAGGG
pNEBRX-Sh-1 HindIII top:
GCTAAAGCTTTGCTGTTGACAGTGAGCGAGTCTGTGA
CTCTTGCATGTACGTGAAGCCACAGATG
pNEBRX-Sh-1 BamHI bottom:
TAGCGGATCCTGCTGAGGCAGTGGGCGGGGTCTGTGAC
TTGCACGTACCATCTGTGGCTTCAC
USER cloning of- pNEBRX-Sh-2, pNEBRX-Sh-3, FLuc-ShG,
FLucShMG
The precise substitution of, Sh-2 Sh-3 and FLuc short
hairpins for the miR-122 short hairpin, without chan-
ging the surrounding genomic DNA was accomplished
using USER technology (NEB) [29]. The plasmid vector
is derived from pNEBRX1-miR-122 and contains all the
sequences of the original plasmid except the miR-122
short hairpin and was generated by whole plasmid
inverse PCR with the following primers containing
USER sites (underlined):
5’ AAACTCTGUAGCCACGAAGGTGTTAACTTCACCT 3’
and
5’ AATCCUTCCCUCGATAAATGTCTTGGCATCGTTTGC
3’.
The short hairpin inserts were constructed by anneal-
ing and extending oligonucleotides (listed below) with
USER sites corresponding to the vector at their 5’ ends
(underlined), and short regions of complementarity at
their 3’ ends, .50 pmoles of top oligo was annealed with
50 pmoles of bottom oligo in 10 mM Tris pH7.2, by
heating to 95°C for 5 minutes, then cooling slowly to
25°C. Oligonucleotides were extended using Pfu Turbo
Pol Cx (Stratagene).
Vector and insert were mixed, digested with USER
enzyme for 15 minutes at 37°C, annealed for 15 minutes
at 25°C, then transformed into competent E. coli strain
NEB5alpha. (NEB).
Oligonucleotide sequences for USER cloning:
Sh-2 top:
ACAGAGTTUTGCTGTTGACAGTGAGCGAGTCTGT
GACTCTTGCATGTACGTGAAGCCACAGATG
Sh-2 bottom:
AGGGAAGGATUTGCTGAGGCAGTGGGCGGGTCTGT
GACTTGCACGTACCATCTGTGGCTTCAC
Sh-3 top:
ACAGAGTTUCCTTAGCAGAGCTGTGGGTACGTGCAAGT
CACAGACTGTCTAAACTATGTC
Sh-3 bottom:
AGGGAAGGATUGCCTAGCAGTAGCTATTTGTACGTG
TAAGTCACAGACATAGTTTAGACAGT
Fluc-ShG top: ACAGAGTTUCCTTAGCAGAGCTGTC
GAAGTACTCAGCGTAAGTGATGTCTAAACTAT
FLuc-ShG bottom: AGGGAAGGATUGCCTAGCAG
TAGCTATTTAAGTACTCAGCGTAAGTGAATAGTTTAGAC
Fluc-ShMG top: ACAGAGTTUCCTTAGCAGAGCTGT
CGAAGTACTCAGCGTAAGTGATGTCTAAACTAT
Fluc-ShMG bottom: AGGGAAGGATUGCCTAGCAG-
TAGCTATTTAAGTACTTAGCGTAAGT GAATAGTTTAGAC
Cloning glycogen synthase (GYS) 3’ UTR
GYS 3’UTR was cloned by from HEK293-A7 cell polyA
+ RNA by RT-PCR using the Protoscript First Strand
cDNA Synthesis kit (NEB) and 2× Taq mix (NEB). The
GYS PCR primers contained USER enzyme (NEB) clea-
vage sites. RT-PCR products were cleaved with USER
enzyme (NEB), mixed with pNEB206A USER vector and
transformed into competent E. coli strain NEB5alpha
(NEB). The resulting plasmid was digested with NotI
and XhoI and the 3’UTR-containing fragment was
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following oligonucleotide primers were used: GGGAA-
GUGCGGCCGCGTCCGCCCCACCACACTCCCCGCCTGTC
(2395-2422) and GGAGACAUACCGGTTCATCT-
CATCTCCGGACACACTCCATTCA (3528-3500). Coordi-
nates are from human GYS sequence, accession number
NM_002103.
Cloning miR122 target into reporter plasmid pTK-GLuc
Oligonucleotides encoding two direct repeats of a
sequence complementary to the miR-122 guide strand
were annealed by heating to 95°C and cooling slowly to
25°C in 10 mM TRIS pH7.2. The resulting double
stranded DNA fragment containing NotI and XhoI
cohesive ends was ligated to pTK-GLuc (NEB) digested
with NotI and XhoI to produce pTK-GLuc-miR122. Oli-
gonucleotide sequences:
GCGGCCGCACAAACACCATTGTCACACTCCAAATCACA-
CAAACACCATTGTCACACTCCAC and TCGAGTGGAG
TGTGACAATGGTGTTTGTGTGATTTGGAGTGTGACAAT
GGTGTTTGTGC
All restriction endonucleases were obtained from New
England BioLabs (NEB).
Cell culture
NIH3T3-47, HEK-293-A7 Rheoswitch cells (NEB), and
NIH3T3-47/miR122 cells were cultured in DMEM
(HyClone) supplemented with 10% fetal bovine serum
(FBS), 1× non-essential amino acids, 2 mM L-glutamine,
and 800 μg/mL geneticin (G418) (all from GIBCO). In
addition, NIH3T3-47/miR122 cells were cultured with 1
μg/ml puromycin (Sigma). Cells were grown at 37°C, in
5% CO2 atmosphere.
NIH3T3-47/X1-miR122 (puro) stable cell lines
NIH3T3-47 Rheoswitch cells were plated in DMEM
with 10% FBS (as described) in 100 mm plates. Cells
were transfected at approximately 50% confluence with
15 μg pNEBRX1-miR122 (puro) per plate. 24 hours
post-transfection, cells were treated with 1 μg/mL puro-
mycin (Sigma). Cell culture medium was changed as
necessary until colonies formed. Colonies were
expanded and tested for RSL1-inducible expression of
miR-122 by northern blot hybridization. The stable cell
lines were cultured as described above with the addition
of 1 μg/mL puromycin (Sigma).
Transfection and induction
For miR-122 target knockdown experiments, NIH3T3-
47/miR122 cells were plated as described in 12 well
plates and transfected at 50-70% confluence with 800
ng/well reporter plasmid and 100 ng/well pCMV-lacZ as
a control for transfection efficiency, using Transpass D2
reagent (NEB) according to manufacturer’s instructions.
Reporters used were pTK-GLuc, pTK-GLuc-miR122,
pTK-GLuc-GYS.
For FLuc knockdown experiments, NIH3T3-47 Rheos-
witch cells (NEB) were plated as above in 24 well plates
and transfected with 200 ng/well pGL3-FLuc, 100 ng/
well pCMV-lacZ as transfection efficiency control and
100 ng/well of the plasmids encoding the firefly lucifer-
ase short hairpins (pNEBRX1-FLuc-Sh and -Fluc-Sh-M
and pNEBRX1-FLuc-ShG and FLuc-Sh-MG).
Short hairpin expression was induced by addition of
RSL1 (Intrexon) RSL1 is [(N-(2-ethyl-3-methoxybenzo-
lyl)-N’-(3,5-dimethylbenzoytert-butylhydrazine] and has
been also known as GS-E or RG-102240 [16] or Geno-
Stat (Millipore). A 5 mM stock solution in DMSO was
diluted to a final concentration of 500 nM in the culture
medium, unless otherwise noted. Controls received an
equivalent volume of DMSO. DMSO final concentration
was 0.1% or less. Cells were induced at 3-16 hours post-
transfection and cell culture supernatants were collected
for assays at 48 hours post transfection unless otherwise
indicated.
Repeated Induction protocol (Figure 1f). NIH3T3-47/
miR-122 cells were plated in 12 well plates in complete
medium supplemented with 500 nM RSL1 dissolved in
DMSO, or an equivalent volume of DMSO (control
medium). RNA was prepared from RSL1 and DMSO
treated cells after 1, 4 and 7 days in culture. For ligand
withdrawal treatment, cells were cultured in complete
medium containing 500 nM RSL1 for 1 day, after which
it was replaced with control medium. RNA was pre-
pared from these cells on days 4 and 7. For re-induction
treatment, cells that had undergone the withdrawal
treatment were cultured in control medium until day 4,
after which it was replaced with medium containing 500
nM RSL1. RNA was prepared from these cells on day 7.
Total RNA was prepared from cells using TRIZOL
reagent (Invitrogen) according to manufacturer’s
instructions.
PAGE: 10-30 μgt o t a lR N Ao r6 0n gm i c r o R N Am a r -
ker (NEB) in 4 M urea loading buffer was heated to 95°
C for 5 minutes, then loaded on 12% polyacrylamide
gels (SequaGel; National Diagnostics) pre-run in 1×
TBE at 250 V for 1 hour prior to loading. Gels were
stained with SYBRGold (Invitrogen) to visualize RNA,
electroblotted to GeneScreen Plus (Perkin-Elmer Life
Sciences) at 300 mA for 30 minutes and UV crosslinked
on optimum setting (Spectorlinker XL1000,
Spectronics).
Probe synthesis
Oligonucleotide probes were labeled as follows: 0.5 pmol
of probe oligo and 12.5 pmol of template oligo were
mixed and heated to 95°C for 1 minute, incubated at
room temperature for 2 minutes than placed on ice.
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alpha-
32P-dATP (6000 Ci/mmole)(DuPont/NEN) and
dH2Ot o1 0μl were added and incubated at 25°C for
1.5 h. Labeled oligo probe was purified over G-25 spin
column (GE Healthcare) and heated to 95°C for 5 min-
utes before adding to hybridization. The following oligo-
nucleotides were used:
Probe complementary to miR-122 guide strand:
ACAAACACCATTGTCACACTCCA
miR-122 guide strand template:
TTTTTTTTTTTGGAGTGTG
Probe complementary to miR-122 passenger strand:
TGGAGTGTGACAATGGTGTTTGT
miR-122 passenger strand template:
TTTTTTTTTTACAAACA
Probe complementary to Sh-1, Sh-2 and Sh-3 guide
strand:GTCTGTGACTTGCACGTAC
Sh-1, Sh-2, Sh-3 guide strand template:
TTTTTTTTTTGTACGTG
Probe complementary to FLuc guide strand:
ATCACTTACGCTGAGTACTTCGA
FLuc guide strand template: TTTTTTTTTTTCGAAGT
Complementary regions of probe and template oligos
are underlined.
U6 oligo probe: 5’CGTTCCAATTTTAGTA-
TATGTGCTGCCGAAGCGA3’ [30] synthesized with a bio-
tin at each end and detected using Phototope Star
Detection Kit for Nucleic Acids (NEB) according to
manufacturer’s instructions.
Hybridization and detection
PAGE Northern blots were hybridized in UltraHyb
Oligo (Ambion) at 37°C (U6) or 42°C (miR-122, FLuc)
washed in 1% SDS, 50 mM sodium phosphate buffer pH
7.2 at 37°C or 42°C. Autoradiography was performed on
Amersham Hyperfilm MP (GE Healthcare).
Western blot
Cells were washed once in 1× PBS, followed by lysis in
1× Luciferase Cell Lysis buffer (NEB) for 15-30 minutes
at 25°C with gentle agitation. Lysates were transferred to
microcentrifuge tubes, cell debris was pelleted by centri-
fugation for 5 minutes at 4°C and lysates were stored at
-20°C. 20 μL of lysate was mixed with 10 μL of 3× SDS-
PAGE gel loading buffer (NEB), samples were heated to
95°C for 5 minutes and loaded on 10-20% polyacryla-
mide/Tris-glycine gel (Novex), run at 150 V in 1×
Laemmli buffer, electroblotted to Immobilon or Immo-
bilon-FL PVDF membrane in 1× Towbin buffer.
Tubulin control: Goat anti-alpha/beta tubulin (Cell
Signaling Technologies) 1:1000 in Tris-buffered saline
with 0.15% Tween20 (TBST), 2.5% milk, 2.5% BSA, fol-
lowed by anti-rabbit-HRP (Cell Signaling Technologies)
1:2000. Detection used the Phototope Western detection
kit (Cell Signaling Technologies);
Rabbit anti-beta tubulin (Cell Signaling Technologies)
diluted 1:1000 in Odyssey buffer (LiCor) with 0.1%
Tween20, followed by goat anti-rabbit-IR800 (LiCor)
1:15,000 in Odyssey buffer with 0.1%Tween 20 and
0.01% SDS. Aldolase A: Goat anti-Aldolase A (Santa
Cruz Biotechnology) 1:200 in Odyssey buffer with 0.1%
Tween 20 followed by donkey anti-goat-IR800, 1:15,000
in Odyssey buffer with 0.1% Tween 20 and 0.01% SDS.
Fluorescent antibodies were detected using LiCor
Odyssey
Reporter Assays
All assays were done in black 96 well microtiter plates
and were read using either an L-max II (Molecular
Devices) or a Mithras (Berthold) luminometer. Gaussia
luciferase assay: 20 μL cell culture supernatant was
diluted with 50 μL 1× PBS, 50 μL1 ×Gaussia Luciferase
Assay reagent (NEB) was injected and a 5 second inte-
gration followed a 2 second delay. Firefly luciferase: cells
were washed in 1× PBS and lysed in 1× Luciferase Cell
Lysis Buffer (NEB) for 15-30 minutes at 25°C with gen-
tle agitation. 20 μL lysate was assayed with 100 μL Luci-
ferase Assay Reagent II (Promega Dual Luciferase Assay
kit) using a 10 second integration following a 2 second
delay. B-gal: cells were washed in 1× PBS and lysed in
1× Luciferase Cell Lysis Buffer (NEB) or Galacto-Light
Lysis buffer (Applied Biosystems). B-gal activity was
assayed using the Galacto-Light kit (Applied Biosystems)
according to the manufacturer’s instructions. P values
were calculated using a two-tailed paired t-test.
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